Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in ...
A major pharmaceutical company is making an announcement on Tuesday regarding growth of biopharma innovation in the Rocket ...
Huntsville site will focus on domestic production of small molecule synthetic and peptide medicines, including Lilly's oral ...
VANCOUVER, BC / ACCESS Newswire / December 9, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") is advancing the development of a next-generation "Melt in Your Mouth" ...
Eli Lilly and Company announced Tuesday it was investing more than $6 billion in a new manufacturing facility in Huntsville, Alabama. The next-generation synthetic medicine active pharmaceutical ...
Amid NIH funding delays, reversals and uncertainty, a scientist at Harvard who studies breast cancer has lost one-third of ...
Ghent is boosting its biopharma hub with cutting-edge infrastructure, world-class research, and a thriving life sciences ...
Pulse Biosciences, Inc. (the "Company" or "Pulse Biosciences"), a company leveraging its novel nPulsetm technology using its proprietary Nanosecond Pulsed Field Ablationtm (nanosecond PFA or nsPFAtm) ...